We provide therapeutic solutions in cardiology addressing niche pathologies such as pulmonary arterial hypertension, as well as more widespread conditions such as angina pectoris and heart failure prevention.
Our franchise in the field of pain treatment covers the entire WHO pain ladder, with NSAIDs in different galenic forms (Step I), tramadol products (Step II), and fentanyl products (Step III).
Our oncology supportive care franchise aims at the management of secondary conditions arising from underlying serious diseases such as cancer or HIV-infection. That includes, oral fungal infections affecting immunocompromised patients and breakthrough cancer pain.
Our respiratory franchise addresses chronic obstructive pulmonary disease (COPD), allergic rhinitis and cough and cold.
Within the urology area, we are targeting conditions such as benign prostatic hyperplasia (BPH) and interstitial cystitis/ painful bladder syndrome.
Our gastrointestinal franchise addresses mostly diarrhea, constipation, biliar dysfunction and gastro-oesophageal reflux disease.